OpZira is a Pennsylvania-based ophthalmic medical device company building diagnostic tools for the early detection and monitoring of ocular disease, with a focus on age-related macular degeneration. Formed in 2025 out of LumiThera's diagnostic product lines after Alcon's acquisition of LumiThera, the company sells the AdaptDx Pro wearable dark adaptometer and an electrophysiology vision-testing platform, and is developing AI-driven quantitative diagnostics. It is led by president and CEO Clark E. Tedford, who co-founded LumiThera.
1
Round
1
Industry
5
Tags
Sep 15, 2026
Latest raise
Funding activity · 1 round
Sep 15, 2026
$2M
Seed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
